{"id":"https://openalex.org/W4389026433","doi":"https://doi.org/10.1096/fasebj.30.1_supplement.1189.5","title":"Tankyrases Are Druggable Targets for the Treatment of Metabolic Disorders","display_name":"Tankyrases Are Druggable Targets for the Treatment of Metabolic Disorders","publication_year":2016,"publication_date":"2016-04-01","ids":{"openalex":"https://openalex.org/W4389026433","doi":"https://doi.org/10.1096/fasebj.30.1_supplement.1189.5"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.30.1_supplement.1189.5","doi":"https://doi.org/10.1096/fasebj.30.1_supplement.1189.5","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.30.1_supplement.1189.5","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063254697","display_name":"Obinna N. Obianom","orcid":"https://orcid.org/0000-0002-2957-6615","observed_orcids":["https://orcid.org/0000-0002-2957-6615"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Obinna Obianom","raw_affiliation_strings":["University of Maryland, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Maryland, Baltimore, MD","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100663926","display_name":"Wei Yang","orcid":"https://orcid.org/0000-0002-7083-7872","observed_orcids":["https://orcid.org/0000-0002-7083-7872"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei Yang","raw_affiliation_strings":["University of Maryland, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Maryland, Baltimore, MD","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071398691","display_name":"Fengtian Xue","orcid":"https://orcid.org/0000-0002-4132-9887","observed_orcids":["https://orcid.org/0000-0002-4132-9887"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fengtian Xue","raw_affiliation_strings":["University of Maryland, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Maryland, Baltimore, MD","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065113416","display_name":"Yan Shu","orcid":"https://orcid.org/0000-0001-8492-1437","observed_orcids":["https://orcid.org/0000-0001-8492-1437"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yan Shu","raw_affiliation_strings":["University of Maryland, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Maryland, Baltimore, MD","institution_ids":["https://openalex.org/I126744593"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I126744593"],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.1307,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.55467936,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"30","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10929","display_name":"Wnt/\u03b2-catenin signaling in development and cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10929","display_name":"Wnt/\u03b2-catenin signaling in development and cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tankyrase","display_name":"tankyrase","score":0.6949999928474426},{"id":"https://openalex.org/keywords/xav939","display_name":"XAV939","score":0.9929999709129333},{"id":"https://openalex.org/keywords/wnt-signaling","display_name":"Wnt signaling","score":0.6600000262260437},{"id":"https://openalex.org/keywords/beta-catenin-degradation","display_name":"\u03b2-catenin degradation","score":0.7889999747276306},{"id":"https://openalex.org/keywords/gluconeogenesis","display_name":"gluconeogenesis","score":0.8820000290870667},{"id":"https://openalex.org/keywords/glucose-production","display_name":"glucose production","score":0.7049999833106995},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.968999981880188},{"id":"https://openalex.org/keywords/metabolic-disorders","display_name":"metabolic disorders","score":0.8889999985694885},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.8130000233650208},{"id":"https://openalex.org/keywords/glucose-6-phosphatase","display_name":"glucose-6-phosphatase","score":0.8640000224113464},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.843999981880188},{"id":"https://openalex.org/keywords/cyclin-d1","display_name":"cyclin D1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6029999852180481},{"id":"https://openalex.org/keywords/hepatocytes","display_name":"hepatocytes","score":0.652999997138977},{"id":"https://openalex.org/keywords/glycogen-synthase-kinase","display_name":"glycogen synthase kinase","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C137620995","wikidata":"https://www.wikidata.org/wiki/Q155769","display_name":"Wnt signaling pathway","level":3,"score":0.8579728603363037},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.49157246947288513},{"id":"https://openalex.org/C99732316","wikidata":"https://www.wikidata.org/wiki/Q18032812","display_name":"AXIN2","level":4,"score":0.48836037516593933},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4804639220237732},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4469284117221832},{"id":"https://openalex.org/C182996813","wikidata":"https://www.wikidata.org/wiki/Q910847","display_name":"GSK-3","level":3,"score":0.439619779586792},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4251541793346405},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.38084712624549866}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.30.1_supplement.1189.5","doi":"https://doi.org/10.1096/fasebj.30.1_supplement.1189.5","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.30.1_supplement.1189.5","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2057257265","https://openalex.org/W4416332405","https://openalex.org/W2289501098","https://openalex.org/W2086950529","https://openalex.org/W4414459965","https://openalex.org/W1982313226","https://openalex.org/W2206475047","https://openalex.org/W1872492855","https://openalex.org/W2138528069","https://openalex.org/W2184961837"],"abstract_inverted_index":{"Purpose":[0],"Tankyrases":[1],"(TNKS)":[2],"catalyze":[3],"the":[4,34,40,48,66,76,86,94,134,209,220,233,274,301,309],"poly\u2010ADP\u2010ribosylation":[5],"of":[6,42,68,78,88,96,117,136,173,179,208,225,280,284,304,308,312],"axin,":[7],"targeting":[8],"it":[9],"for":[10,85,133],"ubiquitination":[11],"and":[12,26,65,81,104,127,198,205,214,236,243,251],"proteasomal":[13],"degradation.":[14],"Along":[15],"with":[16,161,187],"adenomatous":[17],"polyposis":[18],"coli":[19],"(APC),":[20],"glycogen":[21],"synthase":[22],"kinase":[23,28],"3":[24],"(GSK3)":[25],"caseine":[27],"1\u03b1":[29],"(CK1\u03b1),":[30],"axin":[31,83,111,281],"makes":[32],"up":[33],"\u03b2\u2010catenin":[35],"destruction":[36],"complex":[37],"that":[38,53,256,278],"promotes":[39],"degradation":[41],"\u03b2\u2010catenin,":[43],"a":[44,60,97,162,177,237],"critical":[45],"effector":[46],"in":[47,62,156,196,288],"canonical":[49],"WNT":[50,102,118],"signaling":[51,103,119,175,211],"pathway":[52,120],"has":[54],"been":[55],"recently":[56],"recognized":[57],"to":[58,74,110,144,260,273],"play":[59],"role":[61],"glucose":[63,226,262],"homeostasis":[64],"pathogenesis":[67],"metabolic":[69,89,290],"disorders.":[70,90],"This":[71,270],"study":[72,271],"sought":[73],"understand":[75],"relevance":[77],"TNKS1/2":[79,98,107,180],"inhibition":[80,108,167,181,283],"subsequent":[82],"stabilization":[84,112,279],"treatment":[87],"Methods":[91],"We":[92],"investigated":[93],"effect":[95,147],"inhibitor,":[99],"XAV939,":[100,232],"on":[101,148],"gluconeogenesis":[105,149,221],"pathway.":[106,150],"leading":[109],"was":[113,142,228,258],"measured":[114],"by":[115,182,231],"repression":[116],"using":[121,249],"dual":[122],"luciferase":[123],"assay.":[124],"Western":[125,184],"blots":[126],"quantitative":[128],"PCR":[129],"analysis":[130,186],"were":[131,217],"employed":[132],"assessment":[135],"gene":[137,223],"expression.":[138],"Glucose":[139,246],"production":[140,247,263],"assay":[141,155],"used":[143],"measure":[145],"direct":[146],"Results":[151],"Cell":[152],"based":[153],"dual\u2010luciferase":[154],"HEK293":[157],"cells":[158,193],"transiently":[159],"transfected":[160],"TCF/LEF\u2010responsive":[163],"reporter":[164],"showed":[165,255],"potent":[166],"(IC":[168],"50":[169],"=":[170],"34":[171],"nM)":[172],"Wnt":[174,210],"as":[176,293],"result":[178],"XAV939.":[183],"blot":[185],"lysates":[188],"from":[189],"XAV939":[190,244,257],"treated":[191],"hepG2":[192,250],"confirmed":[194],"increase":[195],"phospho\u2010\u03b2\u2010catenin":[197],"axin1":[199],"protein":[200,206],"levels.":[201],"More":[202],"so,":[203],"mRNA":[204],"expression":[207,224],"targets":[212],"c\u2010Myc":[213],"cyclin":[215],"D1":[216],"repressed.":[218],"In":[219],"pathway,":[222],"6\u2010phosphatase":[227],"significantly":[229],"decreased":[230],"anti\u2010diabetic":[234],"metformin,":[235],"hybrid":[238],"drug":[239],"containing":[240],"both":[241],"metformin":[242],"(YW1083).":[245],"assays":[248],"mouse":[252],"primary":[253],"hepatocytes":[254],"able":[259],"decrease":[261],"even":[264],"more":[265],"potently":[266],"than":[267],"metformin.":[268],"Conclusion":[269],"adds":[272],"meager":[275],"scientific":[276],"information":[277],"via":[282],"tankyrase1/2":[285],"is":[286],"valuable":[287],"combating":[289],"disorders":[291],"such":[292],"type":[294],"2":[295],"diabetes.":[296],"Support":[297],"or":[298],"Funding":[299],"Information":[300],"National":[302,310],"Institute":[303],"General":[305],"Medical":[306],"Sciences":[307],"Institutes":[311],"Health":[313],"(NIH)":[314],"under":[315],"Award":[316],"R01GM099742":[317]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-11-27T00:00:00"}